149 related articles for article (PubMed ID: 34741990)
1. Analysis of drug residue in needle-exchange syringes in Washington, D.C.
Evans A; Krause M; Leach S; Levitas M; Nguyen L; Short LC
Forensic Sci Int; 2021 Dec; 329():111083. PubMed ID: 34741990
[TBL] [Abstract][Full Text] [Related]
2. Analytical findings in used syringes from a syringe exchange program.
Fiorentin TR; Logan BK
Int J Drug Policy; 2020 Jul; 81():102770. PubMed ID: 32442881
[TBL] [Abstract][Full Text] [Related]
3. Drug residues in used syringes in Switzerland: A comparative study.
Lefrançois E; Augsburger M; Esseiva P
Drug Test Anal; 2018 May; 10(5):874-879. PubMed ID: 29111580
[TBL] [Abstract][Full Text] [Related]
4. A pilot syringe exchange program in Washington, DC.
Vlahov D; Ryan C; Solomon L; Cohn S; Holt MR; Akhter MN
Am J Public Health; 1994 Feb; 84(2):303-4. PubMed ID: 8296961
[TBL] [Abstract][Full Text] [Related]
5. Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE).
Brunt TM; Lefrançois E; Gunnar T; Arponen A; Seyler T; Goudriaan AE; McAuley A; McKeown DA; Detrez V; Csorba J; Deimel D; Auwärter V; Kempf J; Karolak S; Nefau T
Int J Drug Policy; 2021 Sep; 95():103130. PubMed ID: 33487529
[TBL] [Abstract][Full Text] [Related]
6. Fentanyl analog trends in Washington D.C. observed in needle-exchange syringes.
Giltner A; Evans A; Cicco C; Leach S; Rowe W
Forensic Sci Int; 2022 Sep; 338():111393. PubMed ID: 35908338
[TBL] [Abstract][Full Text] [Related]
7. Syringe and needle exchange as HIV/AIDS prevention for injection drug users.
Watters JK; Estilo MJ; Clark GL; Lorvick J
JAMA; 1994 Jan; 271(2):115-20. PubMed ID: 8264065
[TBL] [Abstract][Full Text] [Related]
8. Comparative toxicology of syringe exchange and postmortem blood samples in the District of Columbia: Trends and affinity analysis.
Turley B; Evans A; Benzio K
J Anal Toxicol; 2023 Sep; 47(7):588-596. PubMed ID: 37530762
[TBL] [Abstract][Full Text] [Related]
9. Analysis of residual content of used syringes collected from low threshold facilities in Lausanne, Switzerland.
Lefrançois E; Esseiva P; Gervasoni JP; Lucia S; Zobel F; Augsburger M
Forensic Sci Int; 2016 Sep; 266():534-540. PubMed ID: 27514014
[TBL] [Abstract][Full Text] [Related]
10. Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type.
Lefrancois E; Belackova V; Silins E; Latimer J; Jauncey M; Shimmon R; Mozaner Bordin D; Augsburger M; Esseiva P; Roux C; Morelato M
Drug Alcohol Depend; 2020 Apr; 209():107909. PubMed ID: 32145660
[TBL] [Abstract][Full Text] [Related]
11. Interest in reducing methamphetamine and opioid use among syringe services program participants in Washington State.
McMahan VM; Kingston S; Newman A; Stekler JD; Glick SN; Banta-Green CJ
Drug Alcohol Depend; 2020 Nov; 216():108243. PubMed ID: 32911134
[TBL] [Abstract][Full Text] [Related]
12. A snapshot of injecting drug consumption from the analysis of used syringes within the Medically Supervised Injecting Centre in Sydney, Australia.
Fursman H; Finch E; Xiao L; Lefrançois E; Gupta A; Bartlett M; Latimer J; Chadwick S; Roux C; Morelato M
Drug Alcohol Rev; 2024 Mar; 43(3):787-798. PubMed ID: 38145366
[TBL] [Abstract][Full Text] [Related]
13. Which illicit drugs are injected in Oslo? A study based on analysis of drug residues in used injection equipment and self-reported information.
Gjerde H; Bretteville-Jensen AL; Bache-Andreassen L; Hanoa K; Furuhaugen H; Brochmann GW; Vindenes V
Scand J Public Health; 2023 Feb; 51(1):21-27. PubMed ID: 34538164
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for nonfatal overdose at Seattle-area syringe exchanges.
Jenkins LM; Banta-Green CJ; Maynard C; Kingston S; Hanrahan M; Merrill JO; Coffin PO
J Urban Health; 2011 Feb; 88(1):118-28. PubMed ID: 21246299
[TBL] [Abstract][Full Text] [Related]
15. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
[TBL] [Abstract][Full Text] [Related]
16. Pattern of injecting drug uses and HIV-1 infection: analysis from needle exchange program.
Tellado I; Moran N; Vargas Vidot J; Yamamura Y
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1091-6. PubMed ID: 9449543
[TBL] [Abstract][Full Text] [Related]
17. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.
Heimer R; Kaplan EH; Khoshnood K; Jariwala B; Cadman EC
Am J Med; 1993 Aug; 95(2):214-20. PubMed ID: 8356986
[TBL] [Abstract][Full Text] [Related]
18. Difficulty accessing syringes mediates the relationship between methamphetamine use and syringe sharing among young injection drug users.
Marshall BD; Shoveller JA; Wood E; Patterson TL; Kerr T
AIDS Behav; 2011 Oct; 15(7):1546-53. PubMed ID: 21197598
[TBL] [Abstract][Full Text] [Related]
19. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?
Remis RS; Bruneau J; Hankins CA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S57-9. PubMed ID: 9663625
[TBL] [Abstract][Full Text] [Related]
20. Estimating the Risk of Exposure to Fentanyl in New York City: Testing Drug Residue in Used Syringes.
Blachman-Forshay J; Nolan ML; McAteer JM; Paone D
Am J Public Health; 2018 Dec; 108(12):1666-1668. PubMed ID: 30359110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
